Hepatitis C Infection Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
- Jacksonville, Florida
- +4 more
2022-03-17
Mar 17, 2022M
Active, not recruiting
- BCLC Stage B Hepatocellular Carcinoma
- +10 more
- Elbasvir/Grazoprevir
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022A
Recruiting
- Hepatitis C Infection
- HIV Infection
- Glecaprevir/Pibrentasvir (G/P)
- Ribavirin (RBV)
- San Diego, California
- +15 more
2022-01-11
Jan 11, 2022N
Active, not recruiting
- Cirrhosis
- +8 more
- Laboratory Biomarker Analysis
- +4 more
- Scottsdale, Arizona
- +9 more
2022-01-06
Jan 6, 2022N
Completed
- HIV Infection
- Hepatitis C Infection
- Nitazoxanide (NTZ)
- +2 more
- Birmingham, Alabama
- +17 more
2021-11-02
Nov 2, 2021N
Completed
- Hepatitis C Infection
- HIV Infection
- Nitazoxanide With Pegylated Interferon And Ribavirin
- Washington, District of Columbia
- +3 more
2021-09-14
Sep 14, 2021C
Recruiting
- Hepatitis C Infection
- Clinical examination
- Nîmes, France
- +1 more
2021-08-06
Aug 6, 2021A
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- (no location specified)
2021-07-28
Jul 28, 2021A
M
Terminated
- Hepatitis C Infection
- MBL-HCV1
- +2 more
- Boston, Massachusetts
- +4 more
2021-02-04
Feb 4, 2021M
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
2021-01-15
Jan 15, 2021R
Terminated
- Hepatitis C Infection
- Depression
- Amsterdam, Netherlands
- +6 more
2020-12-04
Dec 4, 2020R
Terminated
- Hepatitis C Infection
- New York, New YorkRockefeller University Hospital
2020-02-20
Feb 20, 2020S
Completed
- Hepatitis C Infection
- SB9200
- Placebo
- Heidelberg, Victoria, Australia
- +3 more
2019-09-17
Sep 17, 2019I
Completed
- Hepatitis C Infection
- HIV
- Peg-interferon + ribavirin under HIV physician supervision
- San Pa Tong, Chiang Mai, Thailand
- +4 more
2019-02-22
Feb 22, 2019I
Completed
- Hepatitis C Infection
- New York, New YorkIcahn School of Medicine
2019-02-25
Feb 25, 2019I
Completed
- Hepatitis C Infection
- New York, New YorkIcahn School of Medicine at Mount Sinai
2019-02-01
Feb 1, 2019M
Completed
- Hepatitis C Infection
- (no location specified)
2018-12-03
Dec 3, 2018U
Completed
- Hepatitis C Infection
- AdCh3NSmut1
- MVA-NSmut
- Dublin, Ireland
- +1 more
2018-10-10
Oct 10, 2018U
Completed
- Hepatitis C Infection
- HIV Infection
- AdCh3NSmut1
- +3 more
- Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine
2018-10-10
Oct 10, 2018C
Completed
- Adult Primary Liver Cancer
- Hepatitis C Infection
- S-adenosyl-L-methionine disulfate p-toluene-sulfonate
- +4 more
- Tucson, Arizona
- +4 more
2018-08-09
Aug 9, 2018H
Completed
- Hepatitis C Infection
- ombitasvir/paritaprevir/ritonavir 8 weeks
- dasabuvir 8 weeks
- Barcelona, SpainCarrion, Jose Antonio, PhD
2018-05-18
May 18, 2018S
Terminated
- Hepatitis C Infection
- ITX 5061
- New York, New YorkMount Sinai School of Medicine
2018-04-16
Apr 16, 2018S
Completed
- Hepatitis C Infection
- Placebo
- +3 more
- San Francisco, California
- +3 more
2017-07-18
Jul 18, 2017U
Terminated
- Hepatitis C Infection
- Thrombocytopenia
- romiplostim
- +4 more
- Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
2017-04-09
Apr 9, 2017